124 related articles for article (PubMed ID: 26147337)
1. Roles of DPY30 in the Proliferation and Motility of Gastric Cancer Cells.
Lee YJ; Han ME; Baek SJ; Kim SY; Oh SO
PLoS One; 2015; 10(7):e0131863. PubMed ID: 26147337
[TBL] [Abstract][Full Text] [Related]
2. DPY30 is required for the enhanced proliferation, motility and epithelial-mesenchymal transition of epithelial ovarian cancer cells.
Zhang L; Zhang S; Li A; Zhang A; Zhang S; Chen L
Int J Mol Med; 2018 Dec; 42(6):3065-3072. PubMed ID: 30221689
[TBL] [Abstract][Full Text] [Related]
3. MED30 Regulates the Proliferation and Motility of Gastric Cancer Cells.
Lee YJ; Han ME; Baek SJ; Kim SY; Oh SO
PLoS One; 2015; 10(6):e0130826. PubMed ID: 26110885
[TBL] [Abstract][Full Text] [Related]
4. The DPY30 subunit in SET1/MLL complexes regulates the proliferation and differentiation of hematopoietic progenitor cells.
Yang Z; Augustin J; Chang C; Hu J; Shah K; Chang CW; Townes T; Jiang H
Blood; 2014 Sep; 124(13):2025-33. PubMed ID: 25139354
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of DPY30 promotes cell proliferation and predicts a poor prognosis in cholangiocarcinoma.
Hong ZF; Zhang WQ; Wang SJ; Li SY; Shang J; Liu F; Shen DY
Biomed Pharmacother; 2020 Mar; 123():109766. PubMed ID: 31846841
[TBL] [Abstract][Full Text] [Related]
6. DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation.
Su WC; Mao XM; Li SY; Luo CY; Fan R; Jiang HF; Zhang LJ; Wang YT; Su GQ; Shen DY
Int J Med Sci; 2023; 20(7):901-917. PubMed ID: 37324189
[TBL] [Abstract][Full Text] [Related]
7. DPY30 functions in glucose homeostasis via integrating activated histone epigenetic modifications.
Liu B
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):286-290. PubMed ID: 30448059
[TBL] [Abstract][Full Text] [Related]
8. FAM107B is regulated by S100A4 and mediates the effect of S100A4 on the proliferation and migration of MGC803 gastric cancer cells.
Guo J; Bian Y; Wang Y; Chen L; Yu A; Sun X
Cell Biol Int; 2017 Oct; 41(10):1103-1109. PubMed ID: 28675500
[TBL] [Abstract][Full Text] [Related]
9. Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer.
Lin YL; Chen HL; Cheng SB; Yeh DC; Huang CC; P'eng FK; Tsai TC; Wu CC; Chen CM
Int J Clin Exp Pathol; 2015; 8(11):14257-69. PubMed ID: 26823742
[TBL] [Abstract][Full Text] [Related]
10. Twist1 correlates with poor differentiation and progression in gastric adenocarcinoma via elevation of FGFR2 expression.
Zhu DY; Guo QS; Li YL; Cui B; Guo J; Liu JX; Li P
World J Gastroenterol; 2014 Dec; 20(48):18306-15. PubMed ID: 25561797
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic roles of the SETDB2 histone methyltransferase in gastric cancer.
Nishikawaji T; Akiyama Y; Shimada S; Kojima K; Kawano T; Eishi Y; Yuasa Y; Tanaka S
Oncotarget; 2016 Oct; 7(41):67251-67265. PubMed ID: 27572307
[TBL] [Abstract][Full Text] [Related]
12. DPY30 regulates cervical squamous cell carcinoma by mediating epithelial-mesenchymal transition (EMT).
He FX; Zhang LL; Jin PF; Liu DD; Li AH
Onco Targets Ther; 2019; 12():7139-7147. PubMed ID: 31564898
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells.
Chivu-Economescu M; Dragu DL; Necula LG; Matei L; Enciu AM; Bleotu C; Diaconu CC
Gastric Cancer; 2017 Nov; 20(6):948-959. PubMed ID: 28299464
[TBL] [Abstract][Full Text] [Related]
14. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
15. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness.
Xue J; Zhu Y; Sun Z; Ji R; Zhang X; Xu W; Yuan X; Zhang B; Yan Y; Yin L; Xu H; Zhang L; Zhu W; Qian H
BMC Cancer; 2015 Oct; 15():793. PubMed ID: 26498753
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
[TBL] [Abstract][Full Text] [Related]
17. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
18. BST2 promotes cell proliferation, migration and induces NF-κB activation in gastric cancer.
Liu W; Cao Y; Guan Y; Zheng C
Biotechnol Lett; 2018 Jul; 40(7):1015-1027. PubMed ID: 29774441
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression.
Akiyama Y; Koda Y; Byeon SJ; Shimada S; Nishikawaji T; Sakamoto A; Chen Y; Kojima K; Kawano T; Eishi Y; Deng D; Kim WH; Zhu WG; Yuasa Y; Tanaka S
Oncotarget; 2016 Jan; 7(4):3966-83. PubMed ID: 26701885
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of DPY30 activity by ASH2L-derived peptides suppresses blood cancer cell growth.
Shah KK; Whitaker RH; Busby T; Hu J; Shi B; Wang Z; Zang C; Placzek WJ; Jiang H
Exp Cell Res; 2019 Sep; 382(2):111485. PubMed ID: 31251903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
